Stockscreener 앱 받기
86.51
0.89%
0.76
시간 외 거래:
86.51
전일 마감가:
$85.75
열려 있는:
$86.35
하루 거래량:
1.90M
Relative Volume:
1.32
시가총액:
$9.85B
수익:
$13.38B
순이익/손실:
$418.00M
주가수익비율:
26.13
EPS:
3.3112
순현금흐름:
$391.00M
1주 성능:
+2.25%
1개월 성능:
+0.09%
6개월 성능:
+18.28%
1년 성능:
+27.26%
1일 변동 폭
$85.73
$87.73
1주일 범위
$83.57
$87.73
52주 변동 폭
$61.95
$89.34
헨리 샤인 Stock (HSIC) Company Profile
명칭
Henry Schein Inc
전화
(631) 843-5500
주소
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
86.51 | 9.64B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
827.14 | 99.52B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
308.37 | 60.54B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
235.60 | 53.72B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.33 | 1.25B | 14.85M | -136.07M | 7.25M | -0.4726 |
헨리 샤인 Stock (HSIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-16 | 개시 | BTIG Research | Neutral |
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-02-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-08-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-07-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-06 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-07-22 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-10 | 업그레이드 | Stifel | Hold → Buy |
| 2022-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-01-31 | 개시 | Morgan Stanley | Underweight |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | 재개 | Credit Suisse | Neutral |
| 2021-02-08 | 재개 | Piper Sandler | Overweight |
| 2021-01-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | 개시 | Wolfe Research | Underperform |
| 2019-05-15 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-01-17 | 개시 | UBS | Sell |
| 2019-01-03 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2019-01-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | 재확인 | Barrington Research | Outperform |
| 2018-10-25 | 다운그레이드 | Edward Jones | Hold → Sell |
| 2018-10-19 | 재개 | Goldman | Neutral |
| 2018-10-04 | 재확인 | Robert W. Baird | Outperform |
| 2018-08-07 | 재확인 | Stifel | Hold |
| 2018-04-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-04-04 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
모두보기
헨리 샤인 주식(HSIC)의 최신 뉴스
UBS Lifts Price Target on Henry Schein to $89 From $85, Maintains Neutral Rating - marketscreener.com
Henry Schein Prepares to Report Q2 Earnings: What's in the Cards? - TradingView
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein Inc (HSIC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth In Medical Distribution - DirectorsTalk Interviews
Henry Schein stock stays tied to earnings, margins and market value. - AD HOC NEWS
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - Fortune
Henry Schein Inc (HSIC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Q4 2025 Henry Schein Inc Earnings Call Transcript - GuruFocus
Henry Schein Inc. (HSIC) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Henry Schein Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Henry Schein Inc (HSIC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HSIC|Henry Schein Inc|Price:85.970|Chg%:+0.500 - TradingKey
HSIC|Henry Schein Inc|Price:85.470|Chg%:+0.940 - TradingKey
Henry Schein, Inc. (HSIC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Henry Schein, Inc. (HSIC) stock price, news, quote and history - Yahoo Finance Australia
Frederick M. Lowery - Long Island Business News
Henry Schein Inc (HSIC) Institutional Confidence - TradingKey
Henry Schein | 4: Statement of changes in beneficial ownership of securities-Officer Popeck Thomas C - Moomoo
Are Investors Undervaluing Henry Schein (HSIC) Right Now? - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Henry Schein (HSIC) Could Be 3% Undervalued As Earnings Come Into Focus - Yahoo Finance
Henry Schein to Report Q2 Earnings: What's in Store for the Stock? - MSN
Black Talon Announces Collaboration with Henry Schein One to Bring Continuous Cyber Readiness to Dental Practices - EIN News
Henry Schein to announce Q2 2026 results on August 4 - scanx.trade
Press Release: Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 A.m. ET - Moomoo
Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET - Yahoo Finance
Henry Schein stock trades steady as dental and medical distribution margins hold after recent earnin - AD HOC NEWS
What to expect from Henry Schein's next quarterly earnings report - MSN
Henry Schein One goes AI-native with AI Product Discovery and Strategy - Amazon Web Services (AWS)
Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Henry Schein stock trades steady as dental and medical demand supports earnings outlook - AD HOC NEWS
Leerink Partners Adjusts Price Target on Henry Schein to $88 From $83, Maintains Market Perform Rating - marketscreener.com
Henry Schein (HSIC) Baird Global Healthcare Conference 2025 Summary - Quartr
Henry Schein stock trades steady as recent earnings highlight margin resilience - ad-hoc-news.de
Henry Schein stock steady as investors weigh margin trends and dental demand - ad-hoc-news.de
Henry Schein stock stays anchored by 2025 sales and margin trends - Ad Hoc News
Henry Schein (HSIC) Q4 2024 earnings summary - Quartr
Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Henry Schein stock hits 52-week high at 89.34 USD - Investing.com UK
Henry Schein stock hits 52-week high at 89.34 USD By Investing.com - Investing.com South Africa
Henry Schein stock reflects steady healthcare distribution business - ad-hoc-news.de
What to Expect From Henry Schein's Next Quarterly Earnings Report - Barchart.com
Henry Schein stock holds steady as dental and medical distribution remains a core healthcare backbon - ad-hoc-news.de
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein stock reflects steady health-care distribution business - ad-hoc-news.de
Multi-year Support for Henry Schein Innovation Laboratory - The Medical University of South Carolina
Henry Schein Modestly Gains as Healthcare Demand Remains ResilientPercent Below MA - DonanımHaber
Is Now The Time To Look At Buying Henry Schein, Inc. (NASDAQ:HSIC)? - Moomoo
BMO Capital Maintains Henry Schein(HSIC.US) With Hold Rating, Raises Target Price to $85 - Moomoo
헨리 샤인 (HSIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
15.29%
10.36%
자본화:
|
볼륨(24시간):